Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.

Han B, Lee-Okada HC, Ishimine M, Orita H, Nishikawa K, Takagaki T, Kajino K, Yokomizo T, Hino O, Kobayashi T
FEBS Open Bio. 2020 Nov;10(11):2375-2387. doi: 10.1002/2211-5463.12985. Epub 2020 Oct 5. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.